- Home
- JLL vs WST Comparison
JLL vs WST Comparison
Compare JLL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JLL | WST |
|---|---|---|
| Founded | 1997 | 1923 |
| Country | United States | United States |
| Employees | 48000 | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 18.5B |
| IPO Year | 1997 | 2004 |
Fundamental Metrics
Financial Performance| Metric | JLL | WST |
|---|---|---|
| Price | $338.47 | $294.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $365.33 | $325.86 |
| AVG Volume (30 Days) | 359.5K | ★ 865.5K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | ★ 45.13 | 1.49 |
| EPS | ★ 16.40 | 1.92 |
| Revenue | ★ $26,115,600,000.00 | $2,886,900,000.00 |
| Revenue This Year | $7.71 | $6.76 |
| Revenue Next Year | $6.99 | $6.22 |
| P/E Ratio | ★ $20.82 | $151.68 |
| Revenue Growth | ★ 11.45 | 1.95 |
| 52 Week Low | $211.86 | $203.74 |
| 52 Week High | $363.06 | $322.34 |
Technical Indicators
Market Signals| Indicator | JLL | WST |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 66.05 |
| Support Level | $334.29 | $257.29 |
| Resistance Level | $359.64 | $322.34 |
| Average True Range (ATR) | 9.54 | 8.47 |
| MACD | 0.27 | 2.47 |
| Stochastic Oscillator | 53.90 | 62.06 |
Price Performance
Historical ComparisonAbout JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $86 billion for clients across diverse public and private real estate strategies.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.